dacarbazine has been researched along with rolipram in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldhoff, P; Hope, A; Jackson, E; Limbrick, DD; Perry, A; Piwnica-Worms, D; Rubin, JB; Warrington, NM; Woerner, BM | 1 |
1 other study(ies) available for dacarbazine and rolipram
Article | Year |
---|---|
Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cyclic Nucleotide Phosphodiesterases, Type 4; Dacarbazine; Female; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Phosphodiesterase Inhibitors; Rolipram; Temozolomide; Xenograft Model Antitumor Assays | 2008 |